CSL Limited
CSL Limited (CSLLY) Revenue
Annual & quarterly revenue history · segment & region breakdown
CSLLY · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsCSL Limited trailing twelve-month (TTM) revenue is $30.52B, an increase of 4.26% year-over-year from $15.43B in FY2025.
Revenue trend
2025 – 2006 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-06-30 | $15.43B | +$0.63B | +4.26% |
| 2024-06-30 | $14.80B | +$1.63B | +12.34% |
| 2023-06-30 | $13.17B | +$2.68B | +25.55% |
| 2022-06-30 | $10.49B | +$0.23B | +2.22% |
| 2021-06-30 | $10.27B | +$1.16B | +12.80% |
| 2020-06-30 | $9.10B | +$0.56B | +6.58% |
| 2019-06-30 | $8.54B | +$2.95B | +52.88% |
| 2018-06-30 | $5.59B | +$0.52B | +10.29% |
| 2017-06-30 | $5.06B | +$0.66B | +14.86% |
| 2016-06-30 | $4.41B | +$0.26B | +6.22% |
Compare revenue vs peers
BiotechnologyCompare CSLLY revenue against listed peers. Click any row to open that company's revenue tab.
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income CSL Limited receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
CSL Limited reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from CSL Limited's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
CSLLY revenue · 4 questionsCSLLY's trailing twelve-month (TTM) revenue is $30.52B. That is an increase of 4.26% year-over-year from $15.43B in FY2025.
▸ Source: FMP · CSL Limited SEC filings · GAAP · CSL Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026